Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Michael Ashton

Professor

Michael Ashton
Professor
michael.ashton@pharm.gu.se
+46 31 786 3412

Postal Address: Box 431, 40530 Göteborg
Visiting Address: Medicinaregatan 13 , 41390 Göteborg


Department of Pharmacolgy at Institute of Neuroscience and Physiology (More Information)
Box 431
405 30 Göteborg
www.neurophys.gu.se/sektioner
farmakologi@gu.se
Fax: +46 31821795
Visiting Address: Medicinaregatan 11-13 , 413 90 Göteborg

About Michael Ashton

Latest publications

Simultaneous quantification of four first line antitubercular drugs and metabolites in human plasma by hydrophilic interaction chromatography and tandem mass spectrometry
Jesper Sundell, E. Bienvenu, Sofia Birgersson, Angela Äbelö, Michael Ashton et al.
Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Journal article 2019
Journal article

Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis
F. Kloprogge, L. Workman, S. Borrmann, M. Tekete, G. Lefevre et al.
Plos Medicine, Journal article 2018
Journal article

MRP2/ABCC2 C1515Y polymorphism modulates exposure to lumefantrine during artemether-lumefantrine antimalarial therapy
K. Vos, C. Lo Sciuto, R. Piedade, Michael Ashton, A. Bjorkman et al.
Pharmacogenomics, Journal article 2017
Journal article

Artemether-lumefantrine coadministration with antiretrovirals; population pharmacokinetics and dosing implications
Richard Höglund, Pauline Byakika‐Kibwika, Mohammed Lamorde, Concepta Merry, Michael Ashton et al.
British Journal of Clinical Pharmacology, Journal article 2015
Journal article

Population pharmacokinetics of artesunate and dihydroartemisinin during long-term oral administration of artesunate to patients with metastatic breast cancer.
Therese Ericsson, Antje Blank, Cornelia von Hagens, Michael Ashton, Angela Abelö
European Journal of Clinical Pharmacology, Journal article 2014
Journal article

Showing 1 - 10 of 60

2019

Simultaneous quantification of four first line antitubercular drugs and metabolites in human plasma by hydrophilic interaction chromatography and tandem mass spectrometry
Jesper Sundell, E. Bienvenu, Sofia Birgersson, Angela Äbelö, Michael Ashton et al.
Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Journal article 2019
Journal article

2018

Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis
F. Kloprogge, L. Workman, S. Borrmann, M. Tekete, G. Lefevre et al.
Plos Medicine, Journal article 2018
Journal article

2017

MRP2/ABCC2 C1515Y polymorphism modulates exposure to lumefantrine during artemether-lumefantrine antimalarial therapy
K. Vos, C. Lo Sciuto, R. Piedade, Michael Ashton, A. Bjorkman et al.
Pharmacogenomics, Journal article 2017
Journal article

2016

2015

Artemether-lumefantrine coadministration with antiretrovirals; population pharmacokinetics and dosing implications
Richard Höglund, Pauline Byakika‐Kibwika, Mohammed Lamorde, Concepta Merry, Michael Ashton et al.
British Journal of Clinical Pharmacology, Journal article 2015
Journal article

2014

Population pharmacokinetics of artesunate and dihydroartemisinin during long-term oral administration of artesunate to patients with metastatic breast cancer.
Therese Ericsson, Antje Blank, Cornelia von Hagens, Michael Ashton, Angela Abelö
European Journal of Clinical Pharmacology, Journal article 2014
Journal article

Showing 1 - 10 of 60

Page Manager: Webbredaktör|Last update: 1/12/2017
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?

Denna text är utskriven från följande webbsida:
http://neurophys.gu.se/english/departments/pharmacology/about-us/staff/?languageId=100001&userId=xashmi
Utskriftsdatum: 2019-10-21